Skip to content


NeuroQuest is a drug development company seeking new approaches to modulation of nerve transmission and promising clinical applications particularly for neuropathic pain. The company focuses on a first-in-class small molecule drug discovery platform which is based on bioactives discovered in plant extracts showing efficacy for neuropathic pain. NeuroQuest is a wholly-owned subsidiary of Neurodyn Life Sciences and a sister company of CNS|CRO, which provides highly predictive neurological animal models to the industry.


Scroll To Top